Comerica Bank
KRTX

Comerica Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Comerica Bank’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-488
Closed -$155K – 3845
2023
Q4 		$155K Buy
488
+39
+9% +$7.58K ﹤0.01% 2346
2023
Q3 		$76K Buy
+449
New +$84.4K ﹤0.01% 2569
2022
Q4 		$3.42M Buy
+17,150
New +$3.68M 0.03% 769

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Comerica Bank's KRTX Position: Q1 2024 in Review

Comerica Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 488 shares — an estimated $155K sold.

Comerica Bank first reported a position in KRTX in Q4 2022 and held it in 3 quarters. The position peaked at $3.42M in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Comerica Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Comerica Bank sold 488 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $155K.
  • Comerica Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Comerica Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $3.42M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Comerica Bank's 13F filing for Q1 2024, filed 16 May 2024.